
Current Price | $369.62 | Mkt Cap | $35.3B |
---|---|---|---|
Open | $367.63 | P/E Ratio | 148.33 |
Prev. Close | $367.50 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $365.28 - $373.99 | Volume | 117,259 |
52-Wk Range | $182.07 - $456.23 | Avg. Daily Vol. | 1,050,510 |
A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes.
Current Price | $369.62 | Mkt Cap | $35.3B |
---|---|---|---|
Open | $367.63 | P/E Ratio | 148.33 |
Prev. Close | $367.50 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $365.28 - $373.99 | Volume | 117,259 |
52-Wk Range | $182.07 - $456.23 | Avg. Daily Vol. | 1,050,510 |
The best Bull and Bear pitches based on recency and number of recommendations.
Great product-market fit, good revenue growth, and a strong strategic plan to capture additional pieces of the diabetes care chain.
The company is having a great year, but based on its price-to-earnings ratio and its PEG, it's still a bit overpriced compared to its peers.
Read the most recent pitches from players about DXCM.
Recs
My partner is a T1D and has never said anything negative about their technology.
Recs
Was recently added to Nasdaq 100, I support it.
~65% gross margin in recent quarters
~18 P/S recently
Quarterly YoY growth numbers:
09-2020 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18 Mar-18
26% 34% 44% 37% 49% 39% 52% 53% 44% 42% 30%
Recs
The company is having a great year, but based on its price-to-earnings ratio and its PEG, it's still a bit overpriced compared to its peers.
Find the members with the highest scoring picks in DXCM.
ardys13 (< 20) Score: +9,482.04
The Score Leader is the player with the highest score across all their picks in DXCM.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
ardys13 | < 20 | 2/9/2009 |
![]() |
1Y | $3.70 | +9,827.84% | +345.80% | +9,482.04 | 1 Comment | |
bigrick22 | 90.59 | 3/24/2008 |
![]() |
NS | $4.00 | +9,083.25% | +197.53% | +8,885.72 | 0 Comment | |
CleverKat | 72.58 | 3/24/2008 |
![]() |
NS | $4.27 | +8,502.58% | +194.29% | +8,308.29 | 0 Comment | |
cpalerm | 94.85 |
|
![]() |
5Y | $4.32 | +8,403.01% | +390.82% | +8,012.18 | 1 Comment | |
MEGIN7790 | < 20 | 4/4/2008 |
![]() |
NS | $4.45 | +8,154.61% | +188.64% | +7,965.97 | 0 Comment | |
LazyTimeMoney | 67.68 | 4/7/2008 |
![]() |
NS | $5.04 | +7,188.29% | +188.15% | +7,000.14 | 0 Comment | |
jabrink | 76.84 | 4/7/2008 |
![]() |
3W | $5.07 | +7,145.17% | +187.92% | +6,957.25 | 0 Comment | |
GriffinRex | 89.13 | 4/8/2008 |
![]() |
3M | $5.17 | +7,005.03% | +191.15% | +6,813.88 | 0 Comment | |
cash4metoo | 58.94 | 5/28/2009 |
![]() |
1Y | $5.34 | +6,778.84% | +327.23% | +6,451.61 | 0 Comment | |
YahooSIRIous | 70.05 | 7/13/2009 |
![]() |
5Y | $5.35 | +6,765.98% | +335.19% | +6,430.79 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.